BIB icon

ProShares Ultra NASDAQ Biotechnology

28 hedge funds and large institutions have $23.7M invested in ProShares Ultra NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
3
Reduced
10
Closed
9
Calls
$5.84M
Puts
$11.2M
Net Calls
-$5.36M
Net Calls Change
-$2.27M
Name Holding Trade Value Shares
Change
Shares
Change %
CG
26
Cutler Group
California
$4K +$4K +100 New
Walleye Trading
27
Walleye Trading
New York
$171 +$155 +3,204 +956%
BG
28
Bellevue Group
Switzerland
-$818K -20,500 Closed
VKH
29
Virtu KCG Holdings
New York
-$466K -11,672 Closed
Jane Street
30
Jane Street
New York
-$416K -10,417 Closed
HF
31
HRT Financial
New York
-$413K -10,360 Closed
Wolverine Trading
32
Wolverine Trading
Illinois
-$274K -6,874 Closed
BPC
33
Banque Pictet & Cie
Switzerland
-$239K -6,000 Closed
VF
34
Virtu Financial
New York
-$213K -5,341 Closed
Simplex Trading
35
Simplex Trading
Illinois
-$96K -2,429 Closed
EWM
36
Edge Wealth Management
New York
-$20K -500 Closed